Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients.
J Crit Care
; 68: 169-171, 2022 Apr.
Article
in English
| MEDLINE | ID: covidwho-1509978
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19 Drug Treatment
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
J Crit Care
Journal subject:
Critical Care
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS